Association between mild parkinsonian signs and mild cognitive impairment in a community

E D Louis1, N Schupf, J Manly

  • 1The Gertrude H. Sergievsky Center, Taub Institute for Research on Alzheimer's Disease, New York, NY, USA. EDL2@columbia.edu

Neurology
|April 13, 2005
PubMed
Abstract

Insights

Mild parkinsonian signs (MPS) are linked to mild cognitive impairment (MCI) in older adults. Rigidity, a specific MPS, was notably associated with amnestic MCI, suggesting shared underlying causes.

Area of Science:

  • Neurology
  • Geriatrics
  • Cognitive Science

Background:

  • Mild parkinsonian signs (MPS) are known risk factors for dementia.
  • The association between MPS and mild cognitive impairment (MCI) remains unclear.

Purpose of the Study:

  • To investigate the relationship between MPS and MCI in nondemented older adults.
  • To identify specific MPS associated with MCI, including axial function, rigidity, and tremor.

Main Methods:

  • Neurologic assessments, including the Unified Parkinson Disease Rating Scale, were performed.
  • Mild cognitive impairment (MCI) was diagnosed using neuropsychological testing in participants without cognitive or functional impairment.
  • Participants with MCI were categorized into MCI with memory impairment (MCI+M) and MCI without memory impairment (MCI-M).

Main Results:

  • Mild cognitive impairment (MCI) was diagnosed in 27.3% of participants.
  • Mild parkinsonian signs (MPS) were present in 16.5% of participants.
  • Participants with MPS had a 51% higher odds of MCI with memory impairment (MCI+M) compared to those without MPS (OR = 1.51). Rigidity was more prevalent in MCI+M.

Conclusions:

  • Mild parkinsonian signs (MPS), particularly rigidity, are associated with amnestic mild cognitive impairment (MCI+M).
  • Shared pathogeneses may underlie MPS and MCI.
  • Further research is needed to explore the role of Alzheimer's pathology, Lewy bodies, or vascular changes.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...